Leading Health and Life Sciences in Nova Scotia

News Release: Athletigen Announces Iris™ The First Genomics App for Human Performance

See original release here HALIFAX, Nova Scotia–(BUSINESS WIRE)–Athletigen Technologies unveiled today the closed release of Iris™, powered by proprietary human performance insights gleaned from their partnerships with world class athletes and performance experts. Iris™ is the first of its kind personalized performance genomics app suite, which merges an athlete’s genetic predispositions with daily monitoring data, empowering coaches and athletes with actionable insights to inform peak performance in training and competition. Built specifically for high performance athletes, Iris™ sits at the intersection of nature and nurture; where an athlete’s genetic traits interface with their environment. After analyzing an athlete’s DNA through a saliva sample, Athletigen reports on genetic markers related to nutrition, recovery and injury protection that can affect training adaptation and performance. Combining genetic insights with daily athlete monitoring of sleep, hunger, mood, training load and more, athletes and coaches are provided a holistic view of human performance data. “Genetics is one very important piece of the human performance puzzle,” explains Dr. Jeremy Koenig, Founder & CEO of Athletigen. “We built Iris to empower athletes to understand how their performance training can be augmented through an understanding of their genetic foundation especially when considered in combination with variables that coaches have considered for more than half a century.” Consisting of the Iris™ Athlete app and Iris™ Coach app, the software suite was built working closely with Olympic athletes and coaches at the ALTIS training center in Phoenix, AZ leading up to the Rio 2016 games. Starting this fall, ALTIS athletes & coaches will be using Iris™ as Athletigen’s official partner and pioneer of human performance research. “Athletigen have taken the hard science behind genetics and its role in athletic performance, meticulously sifted through the noise and wealth of research available to create a product that gives coaches and other practitioners accurate and valuable information about the individuals they work with,” says Mike Boykin, Program Manager & Sprints Coach at ALTIS. “Athletigen uniquely understands that their insight does not replace the information already available, but instead serves to paint a broader picture of each athlete’s gifts and opportunities. At ALTIS, we have not only applied the genetic information to make more informed decisions about an athlete’s, macro, meso, and micro structure of training, but also plan on using their daily monitoring app to better track and make adjustments to the acute and chronic loads we place upon each athlete.” Athletigen is a company driven by science and committed to helping athletes achieve their performance goals. Through genomic innovation with strategic partners, Athletigen works to deliver the most advanced research findings in human performance to its customers. Iris™ is available to select high performance organizations, with the expected release to the general public next year. For more information, visit www.athletigen.com.

About Athletigen Technologies Inc.

At Athletigen, we believe that the more remarkable the athlete, the more unique they are. Our mission is to help them honor their individual training requirements necessary for world class performance. The evolution of our product is driven by intense user research conducted with world class and Olympic athletes, as well as the professionals who train them. As are result, we give high-performers the chance to celebrate their differences and truly nurture their nature.

Contacts

Athletigen Technologies Bryce Crosby, 902-440-2957 [email protected]
]]>

News Release: TruLeaf Adds Ted Grant and Dr. Richard Donald to Management Team

About TruLeaf Founded in 2011, and located in Bible Hill, Nova Scotia, TruLeaf has developed an indoor farming system that grows fresh plants for food and medicines anywhere in the world, regardless of environment, 365 days a year. The system integrates growing technologies in a controlled environment to grow high quality, predictableyield, and clean plants with innovative and efficient technologies. About GoodLeaf Farms GoodLeaf Community Farms Ltd. is a wholly owned subsidiary of TruLeaf Sustainable Agriculture Ltd., and is the exclusive Canadian licensee of the TruLeaf Smart Plant System®. Founded in 2015, and located in Bible Hill, Nova Scotia, GoodLeaf Farms uses innovative vertical farming technology to produce ultra-fresh leafy greens all year long, in a clean and safe indoor environment. By producing greens inside, GoodLeaf eliminates the need for pesticides, herbicides, insecticides and fungicides. Additionally, GoodLeaf’s greens are ready-to-eat because they’ve taken the time to grow them in an ultra-clean environment. GoodLeaf’s goal is to grow delicious leafy greens, hand-pack them at their peak freshness, and get them on customer’s plates within hours of harvesting. For more information please visit: http://www.truleaf.ca Media Contact Greg Veinott [email protected] O: 1 (902) 843-5160 C: 1 (902) 452-6558 90 Research Drive Bible Hill, Nova Scotia B6L 2R2]]>

Athletigen Appoints Former VP of AncestryDNA John Pereira to the Board of Directors

HALIFAX, Nova Scotia–(BUSINESS WIRE)–Athletigen, the industry leader in athlete genomics, today announced the appointment of John Pereira to the Board of Directors. John previously led all Product, Marketing and Operational activities as the VP of AncestryDNA. He was ultimately responsible for taking the latest scientific advancements in human genomics and combining them with the world’s largest resource in family history to provide a new and simple online resource for discovering your past. “I have been involved in the genomics industry for nearly 10 years and after discussions with the Athletigen team, it was an easy decision to join the board,” said Pereira. “I’m excited to join such an amazing team and help advance discovery of genetic influence on athletic performance.” Adding someone as experienced in building genomics products as John was a natural fit for Athletigen. Providing strategic insight for facilitating the development & growth of the Athletigen product, John provides the experience necessary to help define and serve the emerging market of athlete genomics. With this unparalleled understanding of product development & marketing, Athletigen is prepared to deliver genomic insights to athletes around the world. “There are very few people in this industry who can say they have developed a successful genomics product and taken it to market, so to bring John’s experience to Athletigen was an easy decision, “ says Athletigen Founder & CEO, Dr. Jeremy Koenig. “We are delighted to be working with John because he brings world-class industry standards to a product that aims to help its users perform on a global stage.” Athletigen is a company driven by science and committed to helping athletes achieve their performance goals. Through genomic innovation with strategic partners, Athletigen works to deliver the most advanced research findings in human performance to its customers. About Athletigen At Athletigen, we believe that the more remarkable the athlete, the more unique they are and our mission is to help them honor their individual training requirements necessary for world class performance. The evolution of our product is driven by intense user research conducted with world class and Olympic athletes, as well as the professionals who train them. As are result, we give high-performers the chance to celebrate their differences and truly nurture their nature. www.athletigen.com.

Contacts

Athletigen Bryce Crosby, 902-440-2957 [email protected]
]]>

BioPort News: Meet Honorary Conference Chair Dr. Abdullah Kirumira

Dr. Abdullah Kirumira, Chairman and Technical Director, BioMedica Diagnostics  In 1993, Dr. Kirumira was responsible for the invention of the world’s first rapid-acting HIV diagnostic test. In 1999, Dr. Abdullah Kirumira founded BioMedica Diagnostics in Windsor, NS, who’s success has been built on their ability to deliver superior service, quality and results to their partners. Dr. Kirumira’s entrepreneurial spirit and willingness to give back has resulted in impressive levels of support in underdeveloped regions lacking the ability diagnose infectious diseases.

“My vision is to establish affordable laboratory medicine in Third World countries that do not have access to diagnostic equipment because it is too expensive, or they don’t have the appropriate technology at their disposal.” (Source).
 Dr. Kirumira’s achievements have been well recognized and appreciated by a variety of local and international organizations.
Join us at BioPort to hear from one of the key scientist-entrepreneurs in Nova Scotia’s life sciences industry.]]>